menu
    • menu

    Company profile for Berg Health

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BERG is a clinical-stage, artificial intelligence-powered biotech leveraging its proprietary platform, Interrogative Biology®, to map disease and revolutionize treatments across oncology, neurology and rare diseases. By taking a Back to Biology™ approach, BERG is able to identify critical biomarkers that can accelerate the discovery & development of treatments aimed at the most promising therapeutic targets and pathways. BE...
    BERG is a clinical-stage, artificial intelligence-powered biotech leveraging its proprietary platform, Interrogative Biology®, to map disease and revolutionize treatments across oncology, neurology and rare diseases. By taking a Back to Biology™ approach, BERG is able to identify critical biomarkers that can accelerate the discovery & development of treatments aimed at the most promising therapeutic targets and pathways. BERG has leveraged both Interrogative Biology® and traditional R&D methods to develop a robust pipeline of first-in-class product candidates and diagnostics that advance bold innovations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Berg HealthUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Headquarters and Innovation Center, 500 Old Connecticut Path, Framingham, MA 0...
    Telephone
    Telephone
    617) 588-0083
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.berghealth.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/berghealth
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/berghealth

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BERG To Conduct Phase Two Trial For Treatment Of Deadly [GBM]
    BERG To Conduct Phase Two Trial For Treatment Of Deadly [GBM]

    22 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/berg-to-conduct-phase-two-trial-for-treatment-of-deadly-glioblastoma-multiforme-gbm-301253058.html

    PRNEWSWIRE
    22 Mar 2021
    Share Share
    BERG To Present two major medical/clinical research developments on PDAC at ESMO
    BERG To Present two major medical/clinical research developments on PDAC at ESMO

    18 Sep 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/berg-to-present-discovery-validation-of-biomarkers-associated-with-survival-in-pancreatic-ductal-adenocarcinoma-pdac-treated-with-bpm-31510-iv-at-the-european-society-for-medical-oncology-esmo-2020-congress/

    BIOSPACE
    18 Sep 2020
    Share Share
    BERG Presents Results of Phase 1 Clinical Study in Glioblastoma at 2020 ASCO
    BERG Presents Results of Phase 1 Clinical Study in Glioblastoma at 2020 ASCO

    01 Jun 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/berg-presents-results-of-phase-1-clinical-study-in-glioblastoma-at-2020-american-society-of-clinical-oncology-asco-meeting-301068496.html

    PRNEWSWIRE
    01 Jun 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search